Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:CAPDNASDAQ:ECORCVE:EMH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCAPDiPath Shiller CAPE ETN$19.37+0.2%$19.37$17.73▼$23.10$335.88MN/A120,878 shs263,800 shsECORelectroCore$7.57+0.3%$9.52$5.02▼$19.49$54.45M0.8380,323 shs117,191 shsEMHEmerald Health TherapeuticsC$0.26-3.8%C$0.26C$0.15▼C$0.53C$52.28MN/A644,760 shs384,329 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCAPDiPath Shiller CAPE ETN0.00%0.00%0.00%0.00%0.00%ECORelectroCore0.00%+25.75%+11.16%-55.50%+35.66%EMHEmerald Health Therapeutics0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCAPDiPath Shiller CAPE ETNN/AN/AN/AN/AN/AN/AN/AN/AECORelectroCore2.5444 of 5 stars3.52.00.00.02.92.50.6EMHEmerald Health TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCAPDiPath Shiller CAPE ETN 0.00N/AN/AN/AECORelectroCore 3.00Buy$25.50236.86% UpsideEMHEmerald Health Therapeutics 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest EMH, ECOR, CAPD, and GWMO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/13/2025ECORelectroCoreLADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$28.00 ➝ $26.003/13/2025ECORelectroCoreHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$25.00 ➝ $25.00(Data available from 4/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCAPDiPath Shiller CAPE ETNN/AN/AN/AN/AN/AN/AECORelectroCore$25.18M2.16N/AN/A$1.24 per share6.10EMHEmerald Health TherapeuticsC$13.02M4.02C$0.33 per share0.78C$0.40 per share0.64Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCAPDiPath Shiller CAPE ETNN/AN/A0.00∞N/AN/AN/AN/AN/AECORelectroCore-$18.83M-$1.62N/AN/AN/A-54.40%-154.45%-69.16%5/6/2025 (Estimated)EMHEmerald Health TherapeuticsN/A-C$0.70N/A∞N/AN/AN/AN/AN/ALatest EMH, ECOR, CAPD, and GWMO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025ECORelectroCore-$0.56N/AN/AN/A$6.93 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCAPDiPath Shiller CAPE ETNN/A0.00%N/AN/AN/AECORelectroCoreN/AN/AN/AN/AN/AEMHEmerald Health TherapeuticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCAPDiPath Shiller CAPE ETNN/AN/AN/AECORelectroCoreN/A2.121.87EMHEmerald Health Therapeutics35.452.972.61Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCAPDiPath Shiller CAPE ETNN/AECORelectroCore26.74%EMHEmerald Health TherapeuticsN/AInsider OwnershipCompanyInsider OwnershipCAPDiPath Shiller CAPE ETNN/AECORelectroCore19.70%EMHEmerald Health TherapeuticsN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCAPDiPath Shiller CAPE ETNN/A17.34 millionN/ANot OptionableECORelectroCore507.19 million5.35 millionNot OptionableEMHEmerald Health Therapeutics161205.03 millionN/ANot OptionableEMH, ECOR, CAPD, and GWMO HeadlinesRecent News About These CompaniesWomen’s Health Therapeutics Market Size to Reach USD 61.6 Billion by 2032, Driven by Rising Awareness & Technological Advancements - SNS InsiderOctober 17, 2024 | finance.yahoo.comEmerald PrincessMay 24, 2024 | travel.usnews.comUniversity Hospitals Elyria Medical CenterSeptember 23, 2023 | health.usnews.comDigital Therapeutics: Next wave in managing chronic medical conditionsSeptember 13, 2023 | health.economictimes.indiatimes.comThe Digital Therapeutics Market Is GangbustersAugust 29, 2023 | mddionline.comDigital Therapeutics (DTx) For Mental Health Market is Booming and Expected to Grow at a CAGR of 27.42% to 2031 | InsightAce StudyJuly 31, 2023 | finance.yahoo.comEmerald Isle’s Lee Avenue to close again soon as culvert project restartsJuly 15, 2023 | carolinacoastonline.comEfficient Market Hypothesis (EMH): Definition and CritiqueJuly 12, 2023 | investopedia.comRevolutionizing mental health treatment: Vistagen Therapeutics' nasal spray solutionJune 20, 2023 | finance.yahoo.comMenarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Metastatic Breast Cancer at ASCO 2023May 29, 2023 | thaipr.netEmerald Care Center TulsaMay 4, 2023 | health.usnews.comEmerald ReegApril 25, 2023 | health.usnews.comEmerald Expositions GAAP EPS of $0.06, revenue of $93.6MMarch 14, 2023 | msn.comTahoe's Emerald Bay freezes over for first time in decades amid atmospheric riverMarch 13, 2023 | sfgate.comVisus Therapeutics to Attend TD Cowen’s 43rd Annual Health Care ConferenceMarch 4, 2023 | venturebeat.comEmerald community raising money for local dialysis services after political campaigns failFebruary 25, 2023 | abc.net.auNew Digital Therapeutics Company Takes a 'Swing' at FibromyalgiaFebruary 22, 2023 | mddionline.comEmerald Asset Management PA, LLC 30th Annual Emerald Groundhog Day Investment Forum Opens Amid a Stormy 2023 Investment YearJanuary 14, 2023 | finance.yahoo.comEmerald Health Therapeutics Inc (TBD.BE)January 4, 2023 | finance.yahoo.comEmerald Health Therapeutics Announces Revocation of Management Cease Trade OrderJuly 12, 2022 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesAre Tariffs Threatening Disney’s Comeback Story?By Jea Yu | April 9, 2025View Are Tariffs Threatening Disney’s Comeback Story?Energy Transfer: Tariff-Resistant Midstream Resilience By Jeffrey Neal Johnson | April 11, 2025View Energy Transfer: Tariff-Resistant Midstream Resilience AppLovin: Can Record Profits Overcome Market Skepticism?By Jeffrey Neal Johnson | April 19, 2025View AppLovin: Can Record Profits Overcome Market Skepticism?Get Paid With Paychex: Dividends and Higher Prices TooBy Thomas Hughes | March 31, 2025View Get Paid With Paychex: Dividends and Higher Prices Too4 Stocks With +3% Yields and 50+ Years of Dividend IncreasesBy Leo Miller | April 22, 2025View 4 Stocks With +3% Yields and 50+ Years of Dividend IncreasesEMH, ECOR, CAPD, and GWMO Company DescriptionsiPath Shiller CAPE ETN NYSEARCA:CAPD$19.37 +0.04 (+0.21%) As of 10/11/2022electroCore NASDAQ:ECOR$7.57 +0.02 (+0.26%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$7.62 +0.05 (+0.71%) As of 04/25/2025 06:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.Emerald Health Therapeutics CVE:EMHC$0.26 -0.01 (-3.77%) As of 04/26/2021Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 04/21 - 04/25 Bears Can Reap Big Benefits With These 3 Short ETF Bets If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy 3 Stocks To Watch For When Tariffs Subside 3 Boring Stocks Outperforming the Market This Year Short Sellers Gave Up on These 3 Names Recently Churchill Downs Stock: Could Tariff Fears Dampen Derby Gains? Markets Think Robinhood Earnings Could Send the Stock Up Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
